leading biopharmaceutical showcasing event featuring top inventions and startups emerging from public research institutions and universities all over Europe

Joined May 2015
313 Photos and videos
Pinned Tweet
21 Feb 2025
53
18 Dec 2024
We wish you a Merry Christmas and a relaxing holiday season, enjoy the time with your loved ones! Your BioVaria Team 🧡 💙
1
53
24 Sep 2024
#BioVaria2025 We look forward to welcoming you all back to #Munich next year! In the meantime, don't miss any #Biovaria updates and stay up to date by activating the bell icon in the top-right corner of our profile. #savethedate #lifesciences #network #innovation
1
1
83
13 May 2024
Congratulations! 🎉 The #Startup #Award #winners of #BioVaria 2024 are: 🏆QUASAR THERAPEUTICS in the category #Emerging and🏆SurvivX in the category #Rising! We are looking forward to hearing more about these outstanding projects in the future!
68
30 Apr 2024
And with that #BioVaria 2024 comes to an end! Thank you all for joining and see you again next year! :)
1
60
30 Apr 2024
The final presentation at #BioVaria2024 is given by Prof. Sangeun Lee from @Saar_Uni. Her presentation on biodynamers enhancing #DrugDelivery will be the conclusion of the fifth presentation stream. Don’t forget to check out poster A3. #BioVaria #Neurodegeneration, #Biomarker
1
72
30 Apr 2024
Dr. Martin Marek from @MasarykUni continues the presentation stream and shares insights into the coelenterazine-utilizing luciferase #reporters with extremely stable glow-type bioluminescent signal. Check out his poster I5. #BioVaria #Neurodegeneration, #Biomarker #DrugDelivery
52
30 Apr 2024
The next speaker at our #Neurodegeneration, #Biomarker & #DrugDelivery stream is Dr. Mirna Andelic from @NeuroBesta with a presentation about microRNAs as diagnostic biomarkers and therapeutic agents for small fiber neuropathy. Learn more with poster F5. #BioVaria #diagnostics
1
1
61
30 Apr 2024
Our next topic is anti-KLK8 against Alzheimer’s disease and Prof. Kathy Keyvani from @unidue will be the one presenting it. Learn more about it at poster P2. #BioVaria #Neurodegeneration, #Biomarker #DrugDelivery
1
45
30 Apr 2024
The last presentation stream of #BioVaria2024 about #Neurodegeneration, #Biomarker & #DrugDelivery begins and we are happy to start with Prof. Andrea Brancale from @VSCHT introducing a new #treatment for glaucoma. The poster is I6. #BioVaria
38
30 Apr 2024
Join us now for our startup & early-stage innovation award ceremony! #BioVaria 2024
27
30 Apr 2024
lunchbreak at #BioVaria 2024, bon appetit!
1
1
46
30 Apr 2024
Join us now for our EPO Lecture on Evolution and patenting of AI in MedTech! #Biovaria #ExternalLecture
30
30 Apr 2024
And once again, we have reached the end of a presentation stream. Dr. Filippo Spreafico from @IstTumori concludes the stream with his talk on a protective device for subjects with solitary kidney or kidney disease. Check out poster F1. #BioVaria #VascularSystem #PatientCare
46
30 Apr 2024
Dr. Angelica Carandina from Fondazione #IRCCS Ca' Granda Ospedale Maggiore Policlinco with a presentation on highly personalized non-invasive vagus nerve stimulation for the treatment of chronic pain. To find out more, visit poster F4. #BioVaria #VascularSystem #PatientCare
1
65
30 Apr 2024
Continuing with the vascular simulation device for medical training in eco-guided procedures is Dr. Valeria Mauri from Fondazione #IRCCS Policlinico San Matteo. Learn more about the #techonolgy by visiting poster F3. #BioVaria #VascularSystem #PatientCare #technology
32
30 Apr 2024
P1 We are happy to welcome Dr. Jürgen Walkenhorst from our partner @PROvendis. We can’t wait to learn more about extracorporeal apheresis to treat preeclampsia. You can also visit his poster P1. #BioVaria #VascularSystem #PatientCare
1
42
30 Apr 2024
Introducing the novel autotaxin inhibitors, Dr. Mathias Eymery from @EMBLGrenoble is here to share some insights. For further information, visit poster E2. #BioVaria #VascularSystem #PatientCare
1
2
222
30 Apr 2024
The fourth presentation stream on #VascularSystem & #PatientCare opens with Dr. Dirk Pleimes from Trypto Therapeutics, whose poster is H5. The topic is a novel class of tryptophan hydroxylase-1 inhibitors to address unmet medical needs in serotonin-dependent diseases. #BioVaria
1
45
29 Apr 2024
Welcome to the #beergarden @BioVaria 2024! Enjoy the evening!
1
32